Biotechnology Jobs

• Waltham, United States
• US$188,100 – US$313,500 pa
• Director

Leads end-to-end Model-Informed Drug Development and clinical pharmacology strategy across the drug development lifecycle, from first-in-human studies through filing and lifecycle management. Drafts regulatory content for FDA, EMA, CDE, PMDA and ICH submissions, and partners with digital medicine, translational imaging, modelling and data science teams to embed quantitative approaches into asset-level decisions.

MIDD · QSP · AI/ML

• London
• US$188,100 – US$313,500 pa
• Director

Leads end-to-end Model-Informed Drug Development and clinical pharmacology strategy across the drug development lifecycle, from first-in-human studies through filing and lifecycle management. Sits in the Clinical Pharmacology and Quantitative Medicine organisation, partnering with digital medicine, translational imaging, modelling and data science teams, and drafting regulatory content for FDA, EMA and ICH submissions.

MIDD · QSP · AI/ML

• Oxford
• On-site
• Lead · manages people
• Permanent

Build and oversee plant growth and phenotyping facilities, ensuring controlled, reproducible environments in growth chambers and greenhouses. Hands-on player-coach role covering planting, irrigation, pollination, sampling and harvest, plus pest and pathogen management, GMO compliance and phenotype data capture. Also shapes field trial operations and future team hiring.

Controlled Environment Growth Chambers · Greenhouses

• Oxford
• On-site
• Lead · manages people
• Permanent

Lead an independent research group within the Generative Biology Institute, setting the research direction and recruiting postdocs, doctoral students and research assistants. Collaborate across GBI and EIT on engineering biology, genome synthesis and DNA design, supported by facilities including sequencing, automation, bioinformatics and machine learning. Positions span Senior Principal Investigator (tenured professor equivalent) and Principal Investigator (tenure-track equivalent).

Mass Spectrometry · Flow Cytometry · Sequencing +4

• Stevenage
• Hybrid · 2–3 days in office
• Senior

Sits within GSK's Chemical Manufacturing & Control function, running day-to-day tech transfer engagement with manufacturing sites and CMOs while redesigning processes in detail. Shapes NPI launch strategy covering site impact assessment, capacity management, digital twins, scenario planning and virtual line commissioning, and defines the target process, data and agent architecture. Owns the tech transfer package and drives agentification and MES-ready recipe building alongside forward deployed engineering pods.

MES · LIMS · ERP +6

• London
• Hybrid · 2–3 days in office
• Senior

Sits within GSK's CMC function, identifying and sizing AI opportunities across process development science for oligonucleotides, ADCs and monoclonal antibodies. Partners with forward deployed engineering pods to turn ambiguous business problems into scoped, buildable products, and shapes self-driving lab and in silico modelling initiatives.

AI Platforms · ML Platforms

• Waltham, United States
• Hybrid · 2–3 days in office
• Director · manages people

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, regulatory approval and launch. Sets disease-area strategy, chairs governance forums and scientific advisory boards, and line-manages clinical development leads and medical directors within a global matrix team.

AI/ML

• Stevenage
• Hybrid · 2–3 days in office
• Director · manages people

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, regulatory approval and launch. Provides portfolio oversight, chairs governance forums and scientific advisory boards, and line-manages Clinical Development Leads and Medical Directors within a global matrix team.

AI/ML

• London
• Hybrid · 2–3 days in office
• Director · manages people

Leads end-to-end clinical development strategy for a hematology oncology portfolio, from first-in-human studies through registrational trials, regulatory approval and initial launch. Provides program oversight at governance forums, co-leads asset development with matrix partners, and line-manages Clinical Development Leads, Medical Directors and Clinical Scientists. Champions novel approaches such as AI/ML, innovative trial designs and real-world data.

AI/ML

• Upper Providence
• Hybrid · 2–3 days in office
• Director · manages people

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, approval and launch. Sets disease-area strategy, chairs governance forums and advisory boards, and line-manages clinical development leads within a global matrix. Distinct for its portfolio-level enterprise scope and hybrid US/UK/Swiss base.

AI/ML

• Baar Onyx
• Hybrid · 2–3 days in office
• Director · manages people

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, regulatory approval and initial launch. Chairs governance forums, co-leads matrix asset teams and line-manages clinical development leads, medical directors and clinical scientists. Distinct for its portfolio-level scope across early- and late-phase programs and its cross-functional connector role spanning research, translational medicine and commercial strategy.

AI/ML